Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.

Impact · against what's priced in

The finalization of the MiniMed exchange ratio is a mechanical step in a previously announced corporate action and does not fundamentally alter Medtronic's valuation. While the split-off is a key driver, the specific ratio does not provide the financial catalyst needed to move the needle on growth or margin assumptions.

MDT+0.00

Already priced in

The price assumes

Diabetes Group double-digit growth and MiniMed separation optionality